Page 5,635«..1020..5,6345,6355,6365,637..5,6405,650..»

Researchers link left-sided brain injury with greater risk for hospital-acquired infections

Posted: Published on March 1st, 2013

Feb. 28, 2013 Findings published in the March issue of Archives of Physical Medicine & Rehabilitation have implications for translational research into brain-mediated immune defenses, infection control practices and cognitive rehabilitation strategies after stroke and brain injury. West Orange, NJ. February 28, 2013. The March 2013 issue of Archives of Physical Medicine & Rehabilitation, the medical journal of the American Congress of Rehabilitation Medicine, features an article by Kessler researchers Pasquale Frisina, PhD, Ann Kutlik, BA, and A.M. Barrett, MD. The study, "Left-sided brain injury associated with more hospital-acquired infections during inpatient rehabilitation," has implications for further research into brain-mediated immune defenses, infection control practices and cognitive rehabilitation strategies to improve outcomes after stroke and traumatic brain injury. The study was supported by Kessler Foundation and the National Institutes of Health (grant nos. R01NS055808, K24HD062647). The authors, a team of stroke specialists from Kessler Foundation and Kessler Institute for Rehabilitation, report findings of a retrospective study of 2236 inpatients with brain lesions caused by traumatic brain injury or stroke. Hospital-acquired infection (HAI), a common complication that adversely affects outcomes and costs, was defined as infection diagnosed within 48 to 72 hours of admission. Of the 163 patients identified as having … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Researchers link left-sided brain injury with greater risk for hospital-acquired infections

Traumatic Brain Injury (TBI) Legal Resource For People Seeking Legal Options Unveiled at LawsuitLegal.com

Posted: Published on March 1st, 2013

People who have suffered traumatic brain injuries can now learn more about their legal options with a new information resource unveiled by LawsuitLegal.com. The injured can now speak with a real lawsuit attorney and get answers in reference to their injury claim regardless of their location. Fort Lauderdale, FL (PRWEB) February 28, 2013 The regularly updated support information is now available at the official website, and both the injured party and the family of the victim qualify for the legal review being made available. To get help, visitors need only fill out a few details relating to their case using a secure, 100% confidential online form that takes less than 2 minutes to complete. Following the completion of a request a real attorney will review the details and respond as soon as possible. "Our guarantee to you is that you will be treated with the dignity and respect you deserve. Not all cases have merit under the eyes of the law, but everyone deserves to be heard," stated Christopher M. Levin with LawsuitLegal.com. According to the Centers for Disease Control and Prevention (CDC) an estimated 1.7 million people suffer a brain injuries that are traumatic in nature each year in … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Traumatic Brain Injury (TBI) Legal Resource For People Seeking Legal Options Unveiled at LawsuitLegal.com

Support offered for brain injury survivors

Posted: Published on March 1st, 2013

ATKINSON The Brain Injury Association of NH provides Support Group Meetings for brain injury and stroke survivors for the greater Salem/Derry area. A brain injury can be a result of trauma, stroke or other brain disorders. This group meets regularly on the first Tuesday of every month. The next meeting will be held Tuesday. The meetings are held at the Community Crossroads, 8 Commerce Drive in Atkinson from 6:30 to 8 p.m. For more information, call Terri Cadorette at (603) 893-1299, Ext. 321. Derry library welcomes teens DERRY Derry Public Library offers Cafe Days for teens March 5 and 19, April 2, 16 and 30, and May 14, from 3:30 to 4:30 p.m. in Meeting Room A. Its an open forum format with warm drinks. Teens share ideas, brainstorm future programs or share artwork in personal sketch books. The meetings are open to all teens. On Tuesday, representatives from Next Charter School will drop in to answer any questions people may have about the school. All are welcome to attend. Go here to see the original: Support offered for brain injury survivors … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Support offered for brain injury survivors

Kessler researchers link left-sided brain injury with greater risk for hospital-acquired infections

Posted: Published on March 1st, 2013

Public release date: 28-Feb-2013 [ | E-mail | Share ] Contact: Carolann Murphy CMurphy@KesslerFoundation.org 973-324-8382 Kessler Foundation West Orange, NJ. February 28, 2013. The March 2013 issue of Archives of Physical Medicine & Rehabilitation, the medical journal of the American Congress of Rehabilitation Medicine, features an article by Kessler researchers Pasquale Frisina, PhD, Ann Kutlik, BA, and A.M. Barrett, MD. Left-sided brain injury associated with more hospital-acquired infections during inpatient rehabilitation (http://dx.doi.org/10.1016/j.apmr.2012.10.012) has implications for further research into brain-mediated immune defenses, infection control practices and cognitive rehabilitation strategies to improve outcomes after stroke and traumatic brain injury. The study was supported by Kessler Foundation and the National Institutes of Health (grant nos. R01NS055808, K24HD062647). The authors, a team of stroke specialists from Kessler Foundation and Kessler Institute for Rehabilitation, report findings of a retrospective study of 2236 inpatients with brain lesions caused by traumatic brain injury or stroke. Hospital-acquired infection (HAI), a common complication that adversely affects outcomes and costs, was defined as infection diagnosed within 48 to 72 hours of admission. Of the 163 patients identified as having hospital-acquired infections, 60.1% had left-sided lesions. This finding was consistent with the hypothesis that a left-dominant brain immune network (LD-BIN) may … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Kessler researchers link left-sided brain injury with greater risk for hospital-acquired infections

Dr. Alex Sobel Announces Addition of Desiree Cannon as New Esthetician at Anderson Sobel Cosmetic Surgery

Posted: Published on March 1st, 2013

Seattle cosmetic surgeon Dr. Alex Sobel of Anderson Sobel Cosmetic Surgery is pleased to welcome Desiree Cannon to the staff as the newest esthetician. Bellevue, WA (PRWEB) February 26, 2013 As an experienced esthetician, Ms. Cannon has years of experience specializing in skin care treatments. Ms. Cannon has been working for the past decade at some of the top clinics in Washington. She is aware of all the latest technologies and advancements in the industry. Her background makes her one of the most sought-after estheticians in the region. Her eye for attention to detail and her dedication to patients makes her one of the best in the skin care field. Ms. Cannon has offered laser hair removal, microdermabrasion, photo facials, and other major skin care treatments to countless satisfied patients. "Desiree is among the most accomplished medical estheticians in Seattle. Her talent, experience and knowledge shine as she practices her unique and evidence-based approach to esthetic skin care. Having worked closely with Desiree, I can attest to her exceptional technique with chemical peels, lasers and skin care. Please afford her the opportunity to impress you as much as she has I," said Dr. Alex Sobel. For skin care, Seattle treatment … Continue reading →

Posted in MS Treatment | Comments Off on Dr. Alex Sobel Announces Addition of Desiree Cannon as New Esthetician at Anderson Sobel Cosmetic Surgery

March is here, so is Multiple Sclerosis awareness!

Posted: Published on March 1st, 2013

Chances are, you know someone who suffers from Multiple Sclerosis. But MS affects each person differently, so understanding the disease is the key to treatment. March is the perfect month to gain the knowledge,as it's MS awareness month. "It impacts every minute of every day," says Susan Terry who was diagnosed with MS four years ago. "My vision just totally went double one day," says Terry. But for almost ten years before that, she was told by doctors she had Lupus. "You lived a good eight to ten years of life thinking I had Lupus and now all of the sudden I have a whole different thing to deal with," explains Terry. Terry's symptoms include being fatigue, a loss of balance, and worsening eye sight. "That's one of the problems with MS, it's frequently diagnosed wrong or it takes long to get the diagnoses because the symptoms can vary so much from person to person and can also mimic other diseases," explains Terry. Now Terry uses a cane to get around easier. "I wasn't quite sure about it, but when she [doctor] gave it to me and I started using it, it's great. It gives you a little extra security," … Continue reading →

Posted in MS Treatment | Comments Off on March is here, so is Multiple Sclerosis awareness!

Sunovion seeks FDA approval for epilepsy drug

Posted: Published on March 1st, 2013

Sunovion Pharmaceuticals Inc. of Marlboro has filed a new application with the U.S. Food and Drug Administration for its experimental epilepsy drug Stedesa. We are pleased to achieve this regulatory milestone for Stedesa, which, if approved, may offer adult patients living with epilepsy an effective, once-daily, adjunctive treatment option for managing partial-onset seizures, said Fred Grossman, senior vice president of clinical development and medical affairs at Sunovion, in a statement. Adequate seizure control of this most common form of epilepsy remains an unmet medical need for a significant number of patients and Sunovion is committed to providing a treatment option to help address this need. The company said the application for Stedesa is supported by data from three clinical trials that included more than 1,300 patients with partial-onset seizures in 35 countries. The most commonly reported adverse events were dizziness, somnolence, headache, nausea, double vision, vomiting, fatigue, ataxia, blurred vision and vertigo, officials added. Sunovion originally sought FDA approval for Stedesa in March 2009. The drug is currently marketed as Zebinix in Europe by licensee Eisai Europe Ltd. See more here: Sunovion seeks FDA approval for epilepsy drug … Continue reading →

Comments Off on Sunovion seeks FDA approval for epilepsy drug

Docs misleading women on therapy risk?

Posted: Published on March 1st, 2013

(WXYZ) - Older women have been looking to hormone replacement therapy for decades to feel better and fight the effects of menopause. But the FDA and most doctors will tell you that the therapy comes with risks, like a higher chance of cancer or stroke. But as we showed you in our latest investigation, HRC Medical has been telling patients just the opposite. In Tennessee, where HRC Medical is based, the Attorney General there slapped the company with a civil lawsuit, saying its not telling clients the whole story about serious possible side effects of their treatments: things like heart disease, breast cancer and dementia. Nobodys done a test on the particular cocktail of hormones that they were inserting into people, said Jeff Hill, a senior lawyer for the Tennessee Attorney Generals office. That complaint has nearly crippled the company, so here in Michigan their clinics were recently sold to Legacy Medical, a different company providing the same kinds of therapy. Theyre using some of the same doctors and staff, but 7 Action News wanted to see if theyre making the same statements the FDA says are dangerous. We sent an undercover producer inside its Wixom clinic. Right off the … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Docs misleading women on therapy risk?

5 Stocks Under $10 Set to Soar

Posted: Published on March 1st, 2013

WINDERMERE, Fla. (Stockpickr) -- Every day, the market sees certain stocks trading for $10 a share or less experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis. Just take a look at some of the hot movers in the under-$10 complex from Wednesday, including Zogenix (ZGNX), which soared by 40%; First Security Group (FSGI), which ripped higher by 27.9%; Old Second Bancorp (OSBC), which jumped 24.5%; and Meru Networks (MERU), which advanced by 19.7%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading. >>4 Reasons to Buy Stocks in 2013 See if (ARWR) is in our portfolio One low-priced stock that recently exploded higher was nanomedicine player Arrowhead Research (ARWR), which I highlighted in Feb. 20's "4 Biotech Stocks Under $10 Moving Higher" at around $2.04 a share. I mentioned in that piece that shares of ARWR were starting to rebound off its recent low of $1.75 and were quickly moving within range of triggering major breakout trade above some near-term overhead resistance levels at $2.18 to $2.24 … Continue reading →

Comments Off on 5 Stocks Under $10 Set to Soar

Kala Pharmaceuticals Secures $11.5 Million in Series A Financing

Posted: Published on March 1st, 2013

WALTHAM, Mass.--(BUSINESS WIRE)-- Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat a wide range of debilitating diseases, announced today that it has secured $11.5 million in Series A equity financing through new and existing investors. New and lead investor, Crown Venture Fund, LLC, the venture capital arm of the Crown family of Chicago, joined Kalas existing investors, including Lux Capital Management, Polaris Venture Partners and Third Rock Ventures. Proceeds from the financing will be used to advance a portfolio of innovative ophthalmic programs based on Kalas Mucosal Penetrating Product (MPP) platform through clinical proof of concept. "Kala's front of the eye drug delivery advantages and ability to topically deliver a wide variety of drugs to the back of the eye will transform the ophthalmology sector," said Richard Robb, a CVF representative. Crown Venture Fund is pleased to join Kalas existing investors and support this team of ophthalmology industry leaders. With Crown Venture Fund we are pleased to expand our circle of committed, long-term investors who recognize the significant potential of this breakthrough technology, said Guillaume Pfefer, Ph.D., Kalas CEO. This financing provides Kala with the resources to further deploy … Continue reading →

Comments Off on Kala Pharmaceuticals Secures $11.5 Million in Series A Financing

Page 5,635«..1020..5,6345,6355,6365,637..5,6405,650..»